LuminUltra submits COVID-19 diagnostic for approval

By LabPulse.com staff writers

September 14, 2020 -- Molecular diagnostics company LuminUltra has submitted its GeneCount COVID-19 reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay for emergency use authorization with the U.S. Food and Drug Administration (FDA). The Canada-based company also submitted an interim order with Health Canada.

With approvals from the U.S. and Canadian agencies, LuminUltra will be able to provide its complete COVID-19 testing solution for facilities in North America.

The COVID-19 RT-qPCR assay is a part of the company's end-to-end testing solution for the novel coronavirus that can provide test results in under two hours, according to LuminUltra. The company's other COVID-19 offerings include sample collection kits, isolation reagents, and qPCR devices.

BillionToOne wins EUA for RNA extraction-free COVID-19 test
Diagnostics firm BillionToOne has received emergency use authorization (EUA) from the U.S. Food and Drug Administration for its qSanger-COVID-19 assay,...
FDA grants DetectaChem EUA for mobile COVID-19 test
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to DetectaChem for its mobile COVID-19 test kit.
Experts draw lessons from FDA's hydroxychloroquine EUA controversy
Public health and regulatory experts advocated for changes to the U.S. Food and Drug Administration (FDA) emergency use authorization (EUA) process in...
T2's COVID-19 molecular test gets FDA nod
The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to T2 Biosystems for its COVID-19 molecular diagnostic test, T2SARS-CoV-2...
FDA authorizes Abbott's COVID-19 real-time antigen test
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for a COVID-19 antigen test developed by Abbott Diagnostics Scarborough...

Copyright © 2020 LabPulse.com

Last Updated ls 9/21/2020 8:35:49 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current